Open tender

National Generic Pharmaceuticals Project Revive

Contract value
£1
Published 12 Aug 2026

A 22-month national generic pharmaceuticals project seeking supplier participation across multiple regions from April 2027 to January 2029.

United Kingdom· LondonPublished 12 Aug 2026· TodayFind a Tender

Decision brief

4 fields
  • Contract value
    £1nominal
    Pounds sterling
  • Closing date
    Rolling
    No closing date published
  • Sector
    Browse related listings
  • Location
    United Kingdom
    London

Lifecycle

Open

Open tender — no closing date published. Opened today.

12 August 2026
Open tender · no closing date published

Brief

National Generic Pharmaceuticals – Project Revive is a 22-month procurement initiative spanning multiple regional divisions. The project covers DCE/DSW, DLS/DNE, and DLN/DNW regions with a consistent implementation timeline from April 1, 2027 to January 31, 2029. This opportunity invites qualified suppliers to participate in providing generic pharmaceutical products and services across these designated regions during the specified period.

Track record

6 awards · 6 winners
Open panel

Mostly framework call-offs rather than head-to-head competition.

In healthcare medical, NHS ENGLAND has awarded 6 contracts to 6 suppliers.

Who wins here
  1. Amgen Ltd1× · 17%
  2. IMMUNOIVD AB1× · 17%
  3. ImmunoIVD1× · 17%

Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.

More from NHS ENGLAND

4 listingsView all →

Open in Healthcare & Medical

4 open listingsView all →